MHC class I antigens and immune surveillance in transformed cells
- PMID: 17241907
- DOI: 10.1016/S0074-7696(07)56005-5
MHC class I antigens and immune surveillance in transformed cells
Abstract
MHC class I antigens play a crucial role in the interaction of tumor cells with the host immune system, in particular, in the presentation of peptides as tumor-associated antigens to cytotoxic lymphocytes (CTLs) and in the regulation of cytolytic activity of natural killer (NK) cells. In this review we discuss the role of MHC class I antigens in the recognition and elimination of transformed cells and in the generation of tumor immune escape routes when MHC class I losses occur in tumors. The different altered MHC class I phenotypes and their distribution in different human tumors are the main topic of this review. In addition, molecular defects that underlie MHC alterations in transformed cells are also described in detail. Future research directions in this field are also discussed, including the laboratory analysis of tumor MHC class I-negative variants and the possible restoration of MHC class I expression.
Similar articles
-
MHC class I antigens, immune surveillance, and tumor immune escape.J Cell Physiol. 2003 Jun;195(3):346-55. doi: 10.1002/jcp.10290. J Cell Physiol. 2003. PMID: 12704644 Review.
-
Immune selection in murine tumors. Ph.d thesis.APMIS Suppl. 2003;(106):1-46. APMIS Suppl. 2003. PMID: 12739251
-
Suppression of MHC class I antigens in oncogenic transformants: association with decreased recognition by cytotoxic T lymphocytes.Exp Hematol. 1996 Sep;24(11):1275-9. Exp Hematol. 1996. PMID: 8862437
-
MHC class I down-regulation: tumour escape from immune surveillance? (review).Int J Oncol. 2004 Aug;25(2):487-91. Int J Oncol. 2004. PMID: 15254748 Review.
-
Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants.Nat Med. 2006 Apr;12(4):417-24. doi: 10.1038/nm1381. Epub 2006 Mar 19. Nat Med. 2006. PMID: 16550190
Cited by
-
A transcriptome-proteome integrated network identifies endoplasmic reticulum thiol oxidoreductase (ERp57) as a hub that mediates bone metastasis.Mol Cell Proteomics. 2013 Aug;12(8):2111-25. doi: 10.1074/mcp.M112.022772. Epub 2013 Apr 26. Mol Cell Proteomics. 2013. PMID: 23625662 Free PMC article.
-
Natural Killer Cells: The Linchpin for Successful Cancer Immunotherapy.Front Immunol. 2021 Apr 28;12:679117. doi: 10.3389/fimmu.2021.679117. eCollection 2021. Front Immunol. 2021. PMID: 33995422 Free PMC article. Review.
-
Implementing Logic Gates for Safer Immunotherapy of Cancer.Front Immunol. 2021 Nov 4;12:780399. doi: 10.3389/fimmu.2021.780399. eCollection 2021. Front Immunol. 2021. PMID: 34804073 Free PMC article. Review.
-
Prognostic value of the association between MHC class I downregulation and PD-L1 upregulation in head and neck squamous cell carcinoma patients.Sci Rep. 2019 May 22;9(1):7680. doi: 10.1038/s41598-019-44206-2. Sci Rep. 2019. PMID: 31118488 Free PMC article.
-
Novel immunotherapeutic agents and small molecule antagonists of signalling kinases for the treatment of metastatic melanoma.Drugs. 2011 Jul 9;71(10):1233-50. doi: 10.2165/11591380-000000000-00000. Drugs. 2011. PMID: 21770473 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials